Highlights

  • SkinKandy will release its maiden full-year result as a listed company on 25 August 2026.
  • The company listed in May at AUD 2.20 a share after raising AUD 160 million.
  • FY25 prospectus-era figures showed Revenue of about AUD 77.78 million and NPAT of roughly AUD 8.13 million.
  • Store rollout, comparable sales, margins and any overseas expansion commentary will be central to the first listed report card.

SkinKandy has had only a few months to establish itself as a public company, making its first full-year result unusually important. The piercing and jewellery retailer listed in May after a sizeable IPO and has generally held above its issue price. On 25 August, the market gets its first detailed chance to compare the listed growth story with the operating numbers behind it.

Recent Developments

SkinKandy confirmed it will release FY26 results on 25 August 2026, with chief executive Dain Friis and chief financial officer Carl Larzabal scheduled to host an investor call. Since listing, the company has issued little price-sensitive operational news, leaving the upcoming result as the first major post-IPO checkpoint.

The company floated at AUD 2.20 a share on 21 May 2026, raising AUD 160 million and entering the market with a Capitalisation of about AUD 245.7 million. The IPO was upsized during bookbuild and the shares closed their first session above the issue price.

The float was upsized during bookbuild from earlier expectations near AUD 149 million. After listing, the shares generally traded above the AUD 2.20 issue price through the middle of 2026, leaving the maiden result as the first substantial opportunity to test whether the market's early confidence is supported by audited performance.

Why It Matters

SkinKandy's growth case depends on replicating a store format across a larger network without sacrificing unit Economics . Management has indicated a target of opening 15-20 locations a year and has discussed a longer-term network of roughly 180-210 stores. The United Kingdom and United States have also been identified as potential future markets, subject to board approval.

The model combines a service with product sales: customers pay for piercings and then purchase jewellery in the same visit. That mix can support attractive gross margins, but continued expansion still requires disciplined site selection, trained staff and working Capital.

Earnings will show whether recent operating progress is translating into sustainable profitability.

The Assets described above remain central to the company's valuation and strategic direction.

Dividend policy remains one indicator of how management balances Shareholder returns with reinvestment.

Investment requirements remain tied to the expansion and execution milestones outlined above.

Company Overview

Founded in 2010 on Queensland's Sunshine Coast, SkinKandy operates body-piercing studios and sells jewellery in-store and online. The network had grown to about 100 locations across Australia and New Zealand by the time of listing. New Zealand was entered in June 2024, while the core customer base is younger and heavily engaged through Social Media and Digital Marketing . Around the time of listing, secondary reporting put the workforce near 800 people, many of them trained piercers, making labour availability an important operational input as the store network grows.

Financial Snapshot

Prospectus-era FY25 figures showed Revenue of about AUD 77.78 million, up 38.8%, Gross Profit near AUD 64.36 million and NPAT of about AUD 8.13 million, up 33.3%. The network added 21 stores during the year. Some secondary sources quoted lower FY25 figures, likely reflecting different statutory, pro forma or forecast treatments, making the audited listed accounts especially important.

The FY26 prospectus forecast pointed to Revenue of about AUD 88.7 million, gross profit near AUD 79.2 million and NPAT around AUD 8.6 million. The Business paid Dividends before listing, but the post-IPO shareholder-return profile remains to be established. Investors will also assess Operating Cash Flow and the Capital needed to sustain the store rollout.

What to Watch

The 25 August result should provide comparable-store sales, average transaction value, gross Margin and the final FY26 store count. Those metrics will help distinguish genuine store productivity from growth driven mainly by opening more sites. Any update on New Zealand, the proposed UK or US expansion and the pace of new-store openings will shape the longer-term growth assumptions.

Risks

SkinKandy sells discretionary products and services, leaving Demand exposed to weaker household spending. Rapid rollout can also create execution risk if later stores enter less attractive catchments or if skilled piercers cannot be trained quickly enough. Occupancy costs, wages and precious-metal input prices can pressure margins, while the company remains concentrated in a single retail concept. Escrow releases may also increase available share Supply over time.

What Could Validate SkinKandy's IPO Growth Story

SkinKandy reached the ASX with a profitable growth record and a clear store-expansion plan, but its listed history is still too short to judge execution. The first FY26 result will establish a public baseline for margins, store productivity and cash generation. That makes 25 August more than a routine reporting date: it is the first real test of the forecasts used to support the IPO.